Phase 1 Clinical Trial Of TN-301, A Highly Selective HDAC6 Inhibitor With Potential In HFPEF, Shows Target Engagement
| Autor: | Bexon, Martin, Argast, Gretchen, Robertson, Laura, Hoey, Timothy, Vora, Jay, Tingley, Whittemore, Brown, Fran, Schmelzer, Kara |
|---|---|
| Zdroj: | In Journal of Cardiac Failure January 2024 30(1):295-295 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect